ABMD | Dupont Capital Management Corp Reduces Stock Position in Abiomed, Inc. (NASDAQ:ABMD)

Dupont Capital Management Corp trimmed its holdings in shares of Abiomed, Inc.(NASDAQ:ABMD) by 13.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).The institutional investor owned 1,865 shares of the medical equipment provider’s stock after selling 295 shares during the period.Dupont […]Daily Political

ABMD | FDA Approves Abiomed’s Cardiopulmonary Support Technology

(RTTNews) – Abiomed Inc.(ABMD) said Monday that the United States Food and Drug Administration has approved the Abiomed Breethe OXY-1 System, an all-in-one compact cardiopulmonary bypass system.The company plans to have a controlled launch of the Breethe system at hospitals in the United States, with full U.S.commercial availability…Markets Insider